We have evaluated for their potential use in the routine clinical laboratory enzyme-linked immunosorbent assays (ELIsA) for human thyroglobulin antibodies (hTg-Ab) and microsomal antibodies (M-Ab). Results are expressed in terms of an "EUSA Index," based on comparison with a laboratory standard. The specificity of both ELISA assays is shown by dose-dependent inhibition of the hTg-Ab and M-Ab activities of the laboratory standards by the appropriate specific antigens. Similar concentrations of ovalbumin had no significant effect on the standard activity in both assays. For consecutive samples evaluated for hTg-Ab (n = 113)and MAb (n = 106) by ELISA and hemagglutination, rank order analysis of the results showed a highly significant correlation between the methods (r = 0.81, p = <0.001 for hTg-Ab; r = 0.82,p = <0.001 for M-Ab). However, 8/47 (17%) of samples positive in the hTg-Ab ELISA were negativeby hemagglutination, and 7/69(12%)ofsamples positive in the M-Ab ELISA were negative by hemagglutination. We effectively excluded the possibility of false positivity of these specimens by ELISA by blocking specimen positivity with the specific antigens in12 of 14 specimens investigated. We conclude that EUSA techniques forhuman thyroid autoantibodies are sensitive and specific, easy to initiate, objective, and capable of use in large-scale screening. They are superior to standard hemagglutination techniques by having an increased detection rate for hTg-Ab and M-Ab.
screening cutoff value
Circulating thyroid autoantibodies have been widely implicated in the etiology of autoimmune thyroid disease (1), and both human thyroglobulin antibodies (hTg-Ab) and microsomal antibodies (M-Ab) are measured routinely in clinical practice.' Many techniques have been described for their detection, and newer methodologies have evolved. Immunofluorescent detection of thyroid autoantibodies is sensitive and specific (2), but the evaluation is usually nonquantitative, subjective, and not suitable for automation. Hemagglutination with tanned erythrocytes (3), being sensitive, specific, and suitable for commercial use, has replaced earlier techniques such as precipitin reactions (4) and latex fixation (5); however, it is also highly subjective, only semi-quantitative, and generally unsuitable for largescale screening. Furthennore, hemagglutination-inhibition factors have been described in thyrotoxic patients (6). High- 
Materials and Methods

Antigens.
Human thyroglobulin (hTg) was isolated by standard procedures (15) from normal thyroid tissue obtained at autopsy. Tissue was homogenized in phosphatebuffered saline(PBS; pH 7.0, 150 mmol of NaC1 and 10 mmol of KH2PO4 per liter) and centrifuged at 100 000 x g. The supernate was then eluted from a 90 cm x 15 mm column of Sephadex G-200 (Pharmacia Inc., Piscataway, NJ) with PBS, pH 7.0. The portion of eluate corresponding to the first protein peak was rechromatographed on Sepharose 6B (Pharrnacia); the hTg peak was stored in aliquots at -70 #{176}C. Microsomal antigen was isolated as described elsewhere (16). Thyroid tissue from patients with Graves' disease was homogenized in pH 7.4 PBS (150 mmol of NaC1, 8 inmol of KH2PO4 . 7H20, 1.5 mmol of KH2PO4, arid 3 mmol of KC1 per liter), centrifuged at 100 x g for 10 mm, then at 10 000 x g for 20 mm in a Sorvall centrifuge at 4 #{176}C. The resulting supernate was ultracentriftiged at 100 000 x g for 60 mm and the pellet resuspended in PBS (pH 7.4). This process of recentrifugation at 100000 x g was repeated four more times. The final pellet was solubilized in a 1 mJJL solution of Triton X-100 and stored in aliquots at -70 #{176}C. Final protein concentrations were determined by the method of Lowry et al. (17) serum (diluted 100-fold in PBS, pH 7.4) or laboratory standard was added, and left to incubate for 3 h at 37 #{176}C. After three further washes, 100 L of alkaline phosphataselabeled anti-human IgG (diluted 500-fold) was added and incubated for 30 mm at 37 #{176}C. of 10 mg/L in carbonate buffer. We used a 50 gIL gelatin solution in PBS (pH 7.4) to block the remaining binding sites on the plastic wells. Subsequent washing and exposure to hIgG standard or unknown were similar to the assays described above.
Hemagglutination assays.
We made semi-quantitative measurements of hTg-Ab and M-Ab by using tanned turkey erythrocyte hemagglutmnation assays in commercially available kits (Burroughs Wellcome Co., Research Triangle Park, NC).
hTg radioimmunoassay.
We used a double-antibody radioimmunoassay (15) and the hTg purified as described above. hTg-Ab for the immunoassay was kindly supplied by Dr. C. Von Westharp (University of Alberta).
Nonthyroidal
autoantibodies. Antibodies to mitochondria, smooth muscle, nuclear components, and parietal cells were assessed by standard indirect immunofluorescent techniques (19).
Laboratory standards.
A laboratory standard for each of the assays was established with sera found by hemagglutination to be high titer. A single serum positive for M-Ab at 1:102 000 titer was used as standard in the M-Ab ELISA. A pool of sera positive for hTg-Ab at >1:5000 titer was used as standard for the hTg-Ab ELISA. The standards were diluted 100-fold in PBS (pH 7.4) and stored in frozen aliquots at -20 #{176}C. The same standards were used throughout the experiments reported here. ELISA Indec. Patients' results were expressed in terms of an ELI5A Index, derived by dividing the absorbance of the unknown sample by the absorbance of a 10 000-fold dilution of appropriate standard. We subtracted background absorbance, as measured for 50 g of bovine serum albumin per liter of PBS (pH 7.4), from both unknown and standard results.
Use of the Index allowed comparison of data between assays. We used a 10 000-fold dilution of the standards because this value was on the sensitive part of the dose-response curves (see below).
Results
'Checkerboard" analysis.
The optimal antigen concentration for coating the microtitration plates was determined for both assays by analysis of the appropriate laboratory standard at a single dilution on a plate coated with various concentrations of either hTg or microsomal antigen. The maximum difference in absorbance between the laboratory standard and a reference serum negative for thyroid autoantibodies by hemagglutination was at 5 mg/L for microsomal antigen and at 10 mg/L for hTg. The microsomal antigens were incubated at room temperature for 5 h to ensure adequate adsorption to the plastic. To determine the optimal dilution of sera to be used routinely in the assays, we examined dose-response curves of six specimens positive for hTg.Ab by hemagglutination.
The clearest separation of positive from negative sera occurred at 100-fold dilution, where the absorbances of positive samples were two-to 4.5-fold greater than that of the negative. We used this dilution of sera in both the hTg-Ab and the M-Ab ELISA assays.
Kinetic analysis.
Incubation periods for both ELISA systems were evaluated at 4, 22, and 37 #{176}C for 24 h. Absorbance of positive and negative sera was maximum and stable after 3 h at 37 #{176}C for the incubation of the sample, and after 30 mm at 37 #{176}C for the incubation of the enzyme-conjugated anti-hIgG. albumin at a 100 000-fold dilution in both assays. Insets A to Figure 1 Insets B (Figure 1 ) illustrate the inhibition of antibody activities in 5000-fold diluted standard after overnight incubation with the appropriate antigen. Absorbance decreased with prior incubation with increasing concentrations of antigen. The absorbance of the hTg-Ab and M-Ab standard activities was nearly completely, and specifically, inhibited with antigen concentrations of 10 mg/L (inhibition was 96% for hTg-Ab, 95% for M-Ab). With the ovalbumin control at 10 mg/L, however, the inhibition of absorbance was insignificant (inhibition was 3% for hTg-Ab, 7% for M-Ab).
To further assess specificity, we incubated the 5000-fold diluted hTg-Ab standard overnight at 4 #{176}C with increasing concentrations of microsomal antigen; similarly, the 5000- The mean (±SEM) inhibition of the M-Ab ELI5A Indices resulting from prior incubation with hTg in 13 sera positive for both thyroid antibodies by hemagglutination was 10.7% ± 2% (Table 1) .
We concluded that apparent contamination of the microsomal antigen with hTg was unimportant in the specificity of the M-Ab ELISA, a conclusion further supported by analysis of three sera negative for M-Ab but positive for hTg-Ab (at titers of 1:5000, 1:80, and 1:20) by hemagglutmnation, all of which were reported as negative in the M-Ab ELISA. In addition, there was no detectable hTg in a concentration of the microsomal antigen of 7.2 mg/L (greater than that used to coat the microtitration plates) by specific hTg-RIA. These data suggested that inhibition of microsomal antigen in the There was no significant binding of alkaline phosphatase-labeled anti-hIgG to antigen attached to microtitration plates, obviating the possibility of hIgG contamination in the antigen preparation.
Establishment of normal range.
To determine a normal reference interval for both ELISA systems, we used bovine serum albumin, 50 g/L in pH 7.4 PBS, as control because of the known frequent occurrence of thyroid autoantibodies in the "normal" population (20). An ELISA Index for bovine albumin was constructed from a series of 10 assays for each antibody, by using one of the triplicate determinations as background. The mean Index ± 2 SD gave an upper limit of 0.13 in both assays. To determine whether this range was appropriate,
we assessed 16 control sera from hospital personnel with no medical or family history of thyroid disease. The mean ELISA Index ± 2 SD for these 16 controls gave an upper limit for hTg-Ab ELISA of 0.09, and for the MAb ELISA, 0.13. We concluded that an upper limit of 0.13 for the normal range was suitable for both assays.
Comparison
of ELISA and hemagglutination.
For 113 consecutive specimens for hTg-Ab followed by 106 consecutive specimens for M-Ab received by our routine thyroid laboratory, we used both ELISA and hemagglutination to determine hTg-Ab and M-Ab (Figure 2 ). All but two specimens positive by hemagglutination had ELISA Indices outside the designated normal ranges. Most specimens that were negative by hemagglutination had ELISA Indices within the designated normal ranges, but 15 specimens negative by hemagglutination were positive in the ELISA assays. Rank or4er analysis (21) , in which we assigned a value of 1 to all hemagglutination-negative specimens, showed a highly significant correlation between the results by ELISA and those measured by hemagglutination (r = 0.81, p < 0.001 for hTg-Ab; and r = 0.82, p < 0.001 for M-Ab). Eight of 47 (17%) that were positive in the hTg-Ab ELISA were negative for hTg-Ab by hemagglutination, and 7/60 (12%) that were positive in the M-Ab ELISA were negative for M-Ab by hemagglutination. We studied further 14 of these specimens negative by hemagglutination but positive by ELISA, using specificantigen blockade (overnight incubation at 4 #{176}C with hTg or M antigen, 10 mg/L).
Two samples were inhibited by less than 70% specificantigen blockade (Figure 3) . The single specimen that showed no blockade was repeatedly positive in the M-Ab ELISA and unaffected by microsomal antigen (10 mgIL).
Immunofluorescent studies of this serum for autoantibodies (including mitochondrial, smooth muscle, nuclear, and panetal cell antibodies) gave negative results. The ELISA index of the second specimen was repeatedly inhibited by only 30 to 40% with microsomal antigen (10 mgIL) and was negative by the same immunofluorescence screen for antibodies. Appropriate antigen blockade of the remaining specimens resulted in a mean inhibition of the ELISA index of 87% (saM 2.5%). Three sera from patients with primary biliary cirrhosis, positive for mitochondrial antibody (1:40, 1:40, 1:60) and with markedly increased concentrations of serum alkaline phosphatase, were negative in the M-Ab EUSA, indicating that neither increased serum alkaline phosphatase nor mitochondrial antibodies produced false positivity in the assays. As described, the assays have low intra-and interassay CVs, when used with the ELISA Index based on high-titer hemagglutination sera laboratory standards.
Although the derivation of an index assumes a linear rather than a sigmoidal dose-response relationship, we found it simple to apply and convenient for establishing these assays with minimal procedures and reagents. When human monoclonal antibodies to hTg and microsomal antigen become available, then data for standards expressed in mass terms will be simple to derive. Both assay systems were specific for their respective Comparison of ELISA and hemagglutination results revealed that 98% of all specimens determined as negative by EUSA were negative by hemagglutination.
However, 17% of specimens that were positive in the hTg-Ab EusA and 12% that were positive in the M-Ab ELI8A were negative in the respective heinagglutination assays. We considered that these specimens were falsely negative in the hemagglutination assay, false positivity by ELISA having been excluded by blockade of the ELISA activity with the appropriate antigen in all but two specimens. Micelle formation enclosing the microsomal antigen may have been responsible for the poor antigen-induced blockade in these two high-titer sera; increasing the concentration of antigen may have achieved greater inhibition.
We are uncertain whether increased sensitivity or a methodological difference between the ELSA and hemagglutination techniques accounted for this increased detection of thyroid autoantibodies.
Methodological differences have been previously observed (6) to increase the detection rate of hTg-Ab (double-antibody precipitation technique vs hemagglutination).
One interpretation of these observations is the presence of a hemagglutination-inhibition factor, although we have no direct evidence for this. A difference in antibody properties, such as a lack of hemagglutination activity by (14)alsonotedserapositiveformitochondrial antibody to be falsely positive in their M-Ab ELI8A. Three such sera were negative in our experiments.
In conclusion: we describe sensitive and specific ELISA techniques for the detection of human thyroid autoantibodies. These assays are easy to initiate; the reagents used are widely available and can be stored almost indefinitely within the laboratory; the assays could be automated; and they provide objective data. In addition, they are superior to standard hemagglutination techniques as shown by their increased detection rate for both hTg-Ab and M-Ab. We conclude that the ELISA technique is suitable for the routine measurement of human thyroid autoantibodies in the clinical laboratory. 
